theory clinical_35_6
imports Main


begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  CTNNB1Mutation :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  InPatient :: "event ⇒ bool"
  WithMutation :: "event ⇒ entity ⇒ entity ⇒ bool"
  EntailedBy :: "event ⇒ entity ⇒ event ⇒ bool"
  Presence :: "bool"
  NotchInhibitor :: "entity ⇒ bool"
  Treat :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Effectiveness :: "event ⇒ bool"
  Treatment :: "event ⇒ bool"
  WithInhibitor :: "event ⇒ entity ⇒ entity ⇒ bool"
  Implies :: "event ⇒ event ⇒ event ⇒ bool"
  Activation :: "event ⇒ bool"
  SuggestedBy :: "event ⇒ event ⇒ event ⇒ bool"
  PotentialEffectiveness :: "event ⇒ bool"
  Effective :: "event ⇒ bool"
  Given :: "event ⇒ bool"

(* Explanation 1: The activation of a patient with CTNNB1 mutations is entailed by the presence of activating CTNNB1 mutations in the patient. *)
axiomatization where
  explanation_1: "∀x y z e. Patient x ∧ CTNNB1Mutation y ∧ Activating y ∧ InPatient e ∧ Patient e x ∧ WithMutation e x y ∧ EntailedBy e y z ∧ Presence"

(* Explanation 2: The effectiveness of a specific Notch inhibitor in treating a patient is entailed by the effectiveness of the Notch inhibitor and the treatment of the patient with the inhibitor. *)
axiomatization where
  explanation_2: "∀x y z e1 e2. NotchInhibitor x ∧ Patient y ∧ Treat e1 ∧ Agent e1 x ∧ Patient e1 y ∧ WithInhibitor e1 y x ∧ Effectiveness z ∧ EntailedBy e2 z e1 ∧ Treatment e2 ∧ Agent e2 x ∧ Patient e2 y ∧ WithInhibitor e2 y x"

(* Explanation 3: If a specific Notch inhibitor is effective in treating a patient with activating CTNNB1 mutations, it implies the activation of the patient and the effectiveness of the inhibitor. *)
axiomatization where
  explanation_3: "∀x y z e1 e2 e3. NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z ∧ Treat e1 ∧ Agent e1 x ∧ Patient e1 y ∧ WithMutation e1 y z ∧ Effective e1 ⟶ (Implies e2 e1 e3 ∧ Activation e2 ∧ Patient e2 y ∧ Effectiveness e3 ∧ Agent e3 x)"

(* Explanation 4: The potential effectiveness of Notch inhibitors in treating patients with activating CTNNB1 mutations is suggested by the effectiveness of a specific Notch inhibitor in treating a given patient with such mutations. *)
axiomatization where
  explanation_4: "∀x y z e1 e2 e3. NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z ∧ Treat e1 ∧ Agent e1 x ∧ Patient e1 y ∧ WithMutation e1 y z ∧ Effectiveness e1 ∧ Treat e2 ∧ Agent e2 x ∧ Patient e2 y ∧ WithInhibitor e2 y z ∧ Given e2 ∧ SuggestedBy e3 e1 e2 ∧ PotentialEffectiveness e3"


theorem hypothesis:
 assumes asm: "Patient y ∧ CTNNB1Mutation z ∧ Activating z"
  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)
 shows "∃x y z e. NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z ∧ Treat e ∧ Agent e x ∧ Patient e y ∧ WithMutation e y z ∧ May e"
proof -
  (* From the premise, we have the known information about the patient, CTNNB1 mutation, and activation. *)
  from asm have "Patient y ∧ CTNNB1Mutation z ∧ Activating z" <ATP>
  
  (* We can use Explanation 1 to infer the activation of the patient with CTNNB1 mutations. *)
  from explanation_1 and ‹Patient y ∧ CTNNB1Mutation z ∧ Activating z› have "∃e. InPatient e ∧ Patient e y ∧ WithMutation e y z ∧ EntailedBy e z (Activation e)" <ATP>
  
  (* Using Explanation 3, we can derive the effectiveness of the Notch inhibitor in treating the patient with activating CTNNB1 mutations. *)
  then obtain e1 e2 e3 where "NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z ∧ Treat e1 ∧ Agent e1 x ∧ Patient e1 y ∧ WithMutation e1 y z ∧ Effective e1 ∧ Implies e2 e1 e3 ∧ Activation e2 ∧ Patient e2 y ∧ Effectiveness e3 ∧ Agent e3 x" <ATP>
  
  (* We can now show the existence of x, y, z, and e satisfying the required conditions. *)
  then show ?thesis <ATP>
qed

end
